MIFH
LAB icon

Migdal Insurance & Financial Holdings’s Standard BioTools LAB Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-110,807
Closed -$501K – 635
2021
Q1 		$501K Buy
110,807
+68,764
+164% +$378K 0.01% 320
2020
Q4 		$252K Buy
+42,043
New +$276K ﹤0.01% 290

Other funds holding LAB

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Migdal Insurance & Financial Holdings's LAB Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Standard BioTools (LAB) in Q2 2021, closing a stake of 110,807 shares — an estimated $501K sold.

Migdal Insurance & Financial Holdings first reported a position in LAB in Q4 2020 and held it in 2 quarters. The position peaked at $501K in Q1 2021. 113 funds tracked by Wall St. Rank hold LAB as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Standard BioTools position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 110,807 Standard BioTools shares in Q2 2021, an estimated $501K.
  • Migdal Insurance & Financial Holdings first reported a position in Standard BioTools in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Standard BioTools position peaked at $501K in Q1 2021.
  • 113 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.